Conference Coverage

Benefits of lifestyle intervention only brief in some patients with type 2 diabetes


 

AT THE ADA ANNUAL SCIENTIFIC SESSIONS

References

No changes were observed in blood pressure, weight, or physical activity over the course of 12 months in either group.

Although LIFE lacked a third study arm that received usual care, one possible implication of the current findings “may be that diabetes education of any type may be helpful in improving glycemic control, especially in a population that does not normally receive any education,” she said. “Medication adherence may be an easier and more effective strategy to improve glycemic control in this population.”

LIFE was supported by grants from the National Institutes of Health. Dr. Lynch reported having no relevant financial disclosures.

dbrunk@frontlinemedcom.com

Pages

Recommended Reading

Subdermal mini-pump with exenatide superior to sitagliptin in reducing HbA1c
MDedge Family Medicine
VIDEO: ASD doesn’t appear any more prevalent in children with type 1 diabetes
MDedge Family Medicine
Comprehensive diabetic retinopathy screening challenging
MDedge Family Medicine
FDA strengthens kidney warnings on two diabetes drugs
MDedge Family Medicine
Study plots long-term financial impact of diabetes
MDedge Family Medicine
Empagliflozin slows renal disease progression in type 2 diabetes
MDedge Family Medicine
Pioglitazone safe and effective for steatohepatitis in T2DM
MDedge Family Medicine
Artificial pancreas can improve inpatient glycemic control in type 2 diabetes
MDedge Family Medicine
LEADER: Liraglutide lowers CVD risk in type 2 diabetes
MDedge Family Medicine
Long-term metformin use protective against neurodegenerative disease
MDedge Family Medicine